NAVIDEA BIOPHARMACEUTICALS I's ticker is and the CUSIP is 63937X952. A total of 3 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 100 | -90.0% | 0.00% | – |
| Q1 2023 | $0 | – | 1,000 | +400.0% | 0.00% | – |
| Q4 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 200 | -98.1% | 0.00% | – |
| Q2 2022 | $7,000 | -68.2% | 10,500 | -63.3% | 0.00% | – |
| Q1 2022 | $22,000 | -56.0% | 28,600 | -43.0% | 0.00% | – |
| Q4 2021 | $50,000 | -59.0% | 50,200 | -26.2% | 0.00% | – |
| Q3 2021 | $122,000 | -1.6% | 68,000 | 0.0% | 0.00% | – |
| Q2 2021 | $124,000 | +416.7% | 68,000 | +56098.3% | 0.00% | – |
| Q1 2021 | $24,000 | -33.3% | 121 | -28.8% | 0.00% | – |
| Q4 2020 | $36,000 | -60.9% | 170 | -50.1% | 0.00% | – |
| Q3 2020 | $92,000 | +31.4% | 341 | +89.4% | 0.00% | – |
| Q2 2020 | $70,000 | +3400.0% | 180 | +757.1% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 21 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 21 | +2000.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 35,900 | $77,000 | 0.00% |
| SIMPLEX TRADING, LLC | 170 | $36,000 | 0.00% |